Summit Therapeutics, Inc. Logo

Summit Therapeutics, Inc.

National Account Director, Federal Accounts

Posted 15 Days Ago
Be an Early Applicant
Remote
Hiring Remotely in US
220K-250K Annually
Expert/Leader
Remote
Hiring Remotely in US
220K-250K Annually
Expert/Leader
Owns Summit’s federal account strategy for VA, VHA, DoD, DHA, and TRICARE systems ahead of oncology portfolio launch. Responsibilities include federal contracting readiness, FSS contract and pricing management, formulary and pathway access, account planning, stakeholder relationship development, reimbursement navigation, evidence coordination, and compliance with federal pharmaceutical regulations. The role is a senior individual contributor expected to build and lead the federal function as the portfolio expands.
The summary above was generated by AI

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

  • HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

  • HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

  • HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

  • HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

The National Account Director, Federal Accounts owns Summit's relationship with these systems end to end. This is a pre-launch build role: the person in this seat establishes federal contracting readiness, secures formulary and pathway access, and constructs the account architecture that will carry the oncology portfolio through launch and beyond. It is a senior individual contributor position with the expectation of building and leading a federal team as the portfolio expands.

 

Role and Responsibilities:

VA / VHA Access Strategy
  • Build and own senior relationships across VA Pharmacy Benefits Management (PBM) Services, the National Oncology Program Office, VA Central Office clinical leadership, the Medical Advisory Panel, and the VISN Pharmacist Executives Council.
  • Lead national formulary strategy: develop the value dossier and evidence package supporting VA National Formulary review, criteria-for-use development, and prior authorization drug request pathways.
  • Map and prioritize the VISN and facility landscape — the high-volume oncology centers, VA Cancer Care Navigation and TeleOncology programs, and the sites where treatment decisions get made — and build an account plan that reflects where veteran lung cancer volume concentrates.
  • Understand and navigate VA Community Care referral dynamics under the MISSION Act, including how care delivered outside VA facilities affects product access, site of care, and reimbursement.
  • Represent Summit with veteran service organizations and federal oncology professional societies as appropriate, in full coordination with Legal, Compliance, and Corporate Affairs.
DoD / DHA / TRICARE Access Strategy
  • Own relationships with the Defense Health Agency Pharmacy Operations Division, the DoD Pharmacy and Therapeutics Committee, and the TRICARE pharmacy benefit, including Uniform Formulary review timelines and submission requirements.
  • Build account plans for the major Military Treatment Facilities (MTFs) with oncology capability, including Walter Reed National Military Medical Center, Brooke Army Medical Center, Naval Medical Center San Diego, and the Murtha Cancer Center.
  • Navigate TRICARE medical benefit coverage pathways, TRICARE For Life coordination with Medicare, and the referral relationships between MTFs and the purchased care network.
  • Coordinate with the Uniformed Services University and DoD clinical research stakeholders where scientific engagement is appropriate and Medical-led.
Cross-Functional Leadership
  • Partner with Medical Affairs on federal-specific evidence needs, including health economics and outcomes research relevant to the veteran and military populations.
  • Develop and maintain the federal account plan, opportunity pipeline, and business review cadence for senior leadership.
Compliance
  • Conduct all activities in strict accordance with the Anti-Kickback Statute, the False Claims Act, FDA promotional regulations, PhRMA Code, the Federal Acquisition Regulation (FAR) and VA Acquisition Regulation (VAAR), and Summit's compliance policies.
  • All other duties as assigned


Experience, Education and Specialized Knowledge and Skills:

  • Bachelor's degree required; MBA, PharmD, or other advanced degree preferred.
  • Minimum 10+ years of biopharmaceutical commercial experience, with at least 5+ years in federal/government accounts.
  • Demonstrated ownership of an FSS contract, including NAC negotiation and modification, and working command of Federal Ceiling Price and Big Four pricing mechanics.
  • Direct, documented relationships within VA PBM Services, VISN leadership, and/or DHA pharmacy operations.
  • Track record of securing national formulary or criteria-for-use decisions within VA and/or the DoD Uniform Formulary.
  • Experience launching a specialty or oncology product into the federal channel.
  • Working knowledge of buy-and-bill dynamics, Medicare Part B interaction with federal beneficiaries, and specialty distribution.
  • Ability to obtain and maintain access credentials required for entry to federal facilities.
Preferred Qualifications
  • Oncology, immuno-oncology experience.
  • Biologic launch experience, including permanent J-code acquisition and the coverage implications of the transitional Q-code period.
  • Prior military service or direct experience within VHA or the Military Health System.
  • Experience building a federal function from the ground up at a pre-commercial or newly commercial company.
  • Familiarity with the VA National Oncology Program's precision oncology and clinical pathway initiatives.

Competencies

Builds where there is no blueprint. Summit's federal function does not yet exist. This role requires someone who is energized by writing the first version rather than optimizing an inherited one.

Bridges federal and commercial perspectives. Translates federal contracting and acquisition mechanics into commercial terms for internal leadership and translates Summit's clinical value into terms that resonate with federal clinicians and pharmacy executives.

Long-horizon relationship discipline. Federal access is earned over years, not quarters. Cultivates trust with stakeholders who have no sales quota and no reason to move quickly.

Sound judgment under scrutiny. Operates in the most compliance-sensitive channel in U.S. pharmaceuticals with consistently conservative instincts.

Evidence-led. Comfortable leading with data on outcomes, total cost of care, and population burden rather than relationship capital alone.



This is the pay for this position

Pay Transparency
$220,000$250,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

Similar Jobs

Senior level
Artificial Intelligence • Big Data • Healthtech • Software • Biotech
Leads business development and strategic account growth with pharmaceutical and biotechnology partners across the U.S. West and Central regions. Responsibilities include acquiring customers, building pipelines in Salesforce, developing proposals, advancing precision medicine and genomics opportunities, negotiating and closing projects, and collaborating with scientific, commercial, and operational teams. The role focuses on NGS-based assays, biomarker discovery, clinical trial solutions, and companion diagnostics, with approximately 30% domestic and international travel.
Top Skills: Biomarker DiscoveryClinical Trial AssaysCompanion Diagnostics (Cdx)CtdnaGenomic AssaysLiquid BiopsyNext-Generation Sequencing (Ngs)SalesforceSophia Ddm
55 Minutes Ago
Remote
4 Locations
120K-216K Annually
Expert/Leader
120K-216K Annually
Expert/Leader
Other • Utilities
Senior enterprise sales leader responsible for winning Fortune 1000 new logos and expanding strategic accounts. Build C‑suite relationships, architect tailored technology solutions, lead complex multi-stakeholder deals, manage pipeline and forecasting via CRM, and coordinate cross-functional execution for global, high-value clients.
Top Skills: CRM
An Hour Ago
Remote or Hybrid
USA
41K-83K Annually
Mid level
41K-83K Annually
Mid level
Machine Learning • Payments • Security • Software • Financial Services
Provides enterprise technology support through phone, ticketing, and potentially chat channels. Troubleshoots hardware, software, network, access, and application issues; manages incidents and escalations; documents resolutions in ServiceNow or similar ITSM tools; analyzes trends and operations data; supports knowledge management, training, process improvement, and automation; and coaches junior analysts while maintaining customer service, security, and confidentiality standards.
Top Skills: Call Center TechnologiesHardware InfrastructureItsmNetworkingServicenow

What you need to know about the Boston Tech Scene

Boston is a powerhouse for technology innovation thanks to world-class research universities like MIT and Harvard and a robust pipeline of venture capital investment. Host to the first telephone call and one of the first general-purpose computers ever put into use, Boston is now a hub for biotechnology, robotics and artificial intelligence — though it’s also home to several B2B software giants. So it’s no surprise that the city consistently ranks among the greatest startup ecosystems in the world.

Key Facts About Boston Tech

  • Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
  • Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
  • Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
  • Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
  • Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
  • Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account